# Metabolic Effects of Atazanavir/Ritonavir Versus Darunavir/Ritonavir in Combination With Tenofovir/Emtricitabine in naïve HIV-1 Infected Patients

> **NCT01274780** · PHASE4 · COMPLETED · sponsor: **Juan A. Arnaiz** · enrollment: 180 (actual)

## Conditions studied

- HIV-1

## Interventions

- **DRUG:** Darunavir / Ritonavir + Tenofovir / Emtricitabine
- **DRUG:** Atazanavir / Ritonavir + Tenofovir / Emtricitabine

## Key facts

- **NCT ID:** NCT01274780
- **Lead sponsor:** Juan A. Arnaiz
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2013-05
- **Final completion:** 2014-01
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2014-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01274780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01274780, "Metabolic Effects of Atazanavir/Ritonavir Versus Darunavir/Ritonavir in Combination With Tenofovir/Emtricitabine in naïve HIV-1 Infected Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01274780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*